Insiders · CLRB

Chad J Kolean

CFO at Cellectar Biosciences, Inc. (CLRB) since February 2022

Chad J Kolean has filed 9 insider reports with the SEC since February 2022, as CFO at Cellectar Biosciences, Inc. (CLRB). Chad J Kolean made no open-market purchases or sales in the last 12 months. The latest filing, on July 9, 2026, reports grant or award at Cellectar Biosciences, Inc. (CLRB).

Filings
9
Companies
1
Bought on market
$25K
Sold on market
None

Companies where Chad J Kolean is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Cellectar Biosciences, Inc. logo
CLRB
Cellectar Biosciences, Inc.
CFOsince February 20226,418$25K$4.99$1.01-80%Jul 9, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Chad J Kolean with

Other insiders at the same companies

Questions about Chad J Kolean

What is Chad J Kolean's role at Cellectar Biosciences, Inc.?
Chad J Kolean reports to the SEC as CFO at Cellectar Biosciences, Inc. (CLRB), according to the latest filing on July 9, 2026.
How many shares does Chad J Kolean own?
After the latest filing that states it, Chad J Kolean directly owned 6,418 shares of Cellectar Biosciences, Inc. (CLRB). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Chad J Kolean bought or sold stock recently?
The most recent open-market purchase was on July 2, 2025: bought 5,000 shares of Cellectar Biosciences, Inc. (CLRB) for $25K at an average of $4.99.
How do I get alerts when Chad J Kolean files?
Follow Chad J Kolean on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Chad J Kolean (SEC CIK 0001616753). Totals count each trade once, skipping amendments whose original is on file, from Feb 24, 2022 on. View on SEC EDGAR